Profil
Stephen B.
Ruddy worked as Senior Director-Technology Development at Shire ViroPharma, Inc. from 2012 to 2014.
He then worked as Vice President-Pharmaceutical Development at Tesaro, Inc. from 2015 to 2018.
Ruddy's former job titles culminated in his role as Chief Technical Officer & Senior Vice President at Deciphera Pharmaceuticals, Inc. Ruddy earned an undergraduate and doctorate degree from The University of North Carolina at Chapel Hill.
Anciens postes connus de Stephen Ruddy
Sociétés | Poste | Fin |
---|---|---|
TESARO INC | Corporate Officer/Principal | 01/05/2018 |
Shire ViroPharma, Inc.
Shire ViroPharma, Inc. Pharmaceuticals: MajorHealth Technology Shire ViroPharma, Inc. develops and manufactures drugs. It offers treatment for prophylaxis of hereditary angioedema, as well as capsules for the treatment of antibiotic associated pseudomembranous colitis caused by Clostridium difficile infection (CDI) and enterocolitis. The company was founded by Claude H. Nash and Mark A. McKinlay in September 1994 and is headquartered in Exton, PA. | Corporate Officer/Principal | 01/12/2014 |
DECIPHERA PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | - |
Formation de Stephen Ruddy
The University of North Carolina at Chapel Hill | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
DECIPHERA PHARMACEUTICALS, INC. | Health Technology |
Entreprise privées | 2 |
---|---|
Shire ViroPharma, Inc.
Shire ViroPharma, Inc. Pharmaceuticals: MajorHealth Technology Shire ViroPharma, Inc. develops and manufactures drugs. It offers treatment for prophylaxis of hereditary angioedema, as well as capsules for the treatment of antibiotic associated pseudomembranous colitis caused by Clostridium difficile infection (CDI) and enterocolitis. The company was founded by Claude H. Nash and Mark A. McKinlay in September 1994 and is headquartered in Exton, PA. | Health Technology |
Tesaro, Inc.
Tesaro, Inc. Pharmaceuticals: MajorHealth Technology TESARO, Inc. is an oncology-focused biopharmaceutical company, which engages in the research and development of biopharmaceutical products. The firm offers Niraparib products. The company was founded by Leon Oliver Moulder, Jr., Mary Lynne Hedley, and Richard J. Rodgers on March 26, 2010 and is headquartered in Waltham, MA. | Health Technology |